Digestive Diseases and Sciences

, Volume 58, Issue 10, pp 2976–2985 | Cite as

Pain and Opioid Use in Chronic Liver Disease

  • Shari S. Rogal
  • Daniel Winger
  • Klaus Bielefeldt
  • Eva Szigethy
Original Article



Pain is common in patients with liver disease, difficult to treat, and poorly understood.


The aim of this study was to determine factors associated with pain and prescription opioid use in a large cohort of patients with confirmed chronic liver disease.


This was a retrospective cohort study of consecutive patients with chronic liver disease visiting a tertiary-care hepatology clinic. Pain was determined by self-report and rated numerically from 0 to 10. Symptoms of mood and sleep disorders and emotional distress were based on a symptom checklist. Etiology and stage of liver disease and use of prescribed opioids were abstracted from the electronic medical record. Logistic regression was used to establish factors associated with pain and prescription opioid use.


Among 1,286 patients with chronic liver disease, 34 % had pain and 25 % used opioids. The strongest predictor of pain in multivariate modeling was emotional distress (OR 3.66, 95 % CI 2.40–5.64), followed by non-white race (OR 1.87, 95 % CI 1.24–2.79), mood symptoms (OR 1.47, 95 % CI 1.04–2.07), sleep disturbance/fatigue (OR 1.70, 95 % CI 1.24–2.32), and advanced liver disease (Child class B: OR 1.73, 95 % CI 1.15–2.60; Child class C: OR 2.78, 95 % CI 1.49–5.24) compared to no cirrhosis. Emotional distress, mood-related symptoms, and advanced liver disease were also significant predictors of prescription opioid use, as were age, nicotine use, and etiology of liver disease.


This large cohort study demonstrates the high prevalence of pain and opioid use in chronic liver disease. While disease variables contribute to pain, psychological symptoms were most strongly associated with pain and opioid use, providing rationale and target for therapeutic interventions.


Narcotics Cirrhosis Pain management Psychosocial 


  1. 1.
    Marchesini G, Bianchi G, Amodio P, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120:170–178.PubMedCrossRefGoogle Scholar
  2. 2.
    Whitehead AJ, Dobscha SK, Morasco BJ, Ruimy S, Bussell C, Hauser P. Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C. J Pain Sympt Manage. 2008;36:39–45. doi:10.1016/j.jpainsymman.2007.08.013.CrossRefGoogle Scholar
  3. 3.
    Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152:85–92. doi:10.1059/0003-4819-152-2-201001190-00006.PubMedCrossRefGoogle Scholar
  4. 4.
    Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infections and mortality in association with therapies for Crohn’s disease: TREAT registry. Clin Gastroenterol Hepatol. 2006;4:621–630. doi:10.1016/j.cgh.2006.03.002.PubMedCrossRefGoogle Scholar
  5. 5.
    Bekheet SH. Morphine sulphate induced histopathological and histochemical changes in the rat liver. Tissue Cell. 2010;42:266–272. doi:10.1016/j.tice.2010.06.001.PubMedCrossRefGoogle Scholar
  6. 6.
    Bajaj JS, Thacker LR, Wade JB, et al. PROMIS computerised adaptive tests are dynamic instruments to measure health-related quality of life in patients with cirrhosis. Aliment Pharmacol Ther. 2011;34:1123–1132. doi:10.1111/j.1365-2036.2011.04842.x.PubMedCrossRefGoogle Scholar
  7. 7.
    Riley TR III, Koch K. Characteristics of upper abdominal pain in those with chronic liver disease. Dig Dis Sci. 2003;48:1914–1918.PubMedCrossRefGoogle Scholar
  8. 8.
    Van Oudenhove L, Vandenberghe J, Geeraerts B, et al. Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation? Gut. 2008;57:1666–1673. doi:10.1136/gut.2008.158162.PubMedCrossRefGoogle Scholar
  9. 9.
    Alok R, Das SK, Agarwal GG, Salwahan L, Srivastava R. Relationship of severity of depression, anxiety and stress with severity of fibromyalgia. Clin Exp Rheumatol. 2011;29:S70–S72.PubMedGoogle Scholar
  10. 10.
    Kravitz HM, Janssen I, Lotrich FE, Kado DM, Bromberger JT. Sex steroid hormone gene polymorphisms and depressive symptoms in women at midlife. Am J Med. 2006;119:S87–S93. doi:10.1016/j.amjmed.2006.07.010.PubMedCrossRefGoogle Scholar
  11. 11.
    Ewusi-Mensah I, Saunders JB, Wodak AD, Murray RM, Williams R. Psychiatric morbidity in patients with alcoholic liver disease. Br Med J (Clin Res Ed). 1983;287:1417–1419.CrossRefGoogle Scholar
  12. 12.
    Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function. Pain. 1995;61:277–284.PubMedCrossRefGoogle Scholar
  13. 13.
    Laurin JM, DeSotel CK, Jorgensen RA, Dickson ER, Lindor KD. The natural history of abdominal pain associated with primary biliary cirrhosis. Am J Gastroenterol. 1994;89:1840–1843.PubMedGoogle Scholar
  14. 14.
    McKenna O, Cunningham C, Blake C. Socio-demographic and clinical features of Irish iatrogenic hepatitis C patients: a cross-sectional survey. BMC Public Health. 2009;9:232.CrossRefGoogle Scholar
  15. 15.
    daCosta DiBonaventura M, Yuan Y, Wagner J, L’Italien G, Lescrauwaet B, Langley P. The burden of viral hepatitis C in Europe: a propensity analysis of patient outcomes. Eur J Gastroenterol Hepatol. 2012;24:869–877.Google Scholar
  16. 16.
    Louie K, St Laurent S, Forssen U, Mundy L, Pimenta J. The high comorbidity burden of the hepatitis C virus infected population in the United States. BMC Infect Dis. 2012;12:86.PubMedCrossRefGoogle Scholar
  17. 17.
    Oettinger R, Brunnberg A, Gerner P, Wintermeyer P, Jenke A, Wirth S. Clinical features and biochemical data of Caucasian children at diagnosis of autoimmune hepatitis. J Autoimmun. 2005;24:79–84. doi:10.1016/j.jaut.2004.11.009.PubMedCrossRefGoogle Scholar
  18. 18.
    Liu G, DiBonaventura M, Yuan Y, et al. The burden of illness for patients with viral hepatitis C: evidence from a national survey in Japan. Value Health. 2012;15:S65–S71.PubMedCrossRefGoogle Scholar
  19. 19.
    Fouad YM, Makhlouf MM, Khalaf H, Mostafa Z, Raheem EA, Meneasi W. Is irritable bowel syndrome associated with chronic hepatitis C? J Gastroenterol Hepatol. 2010;25:1285–1288. doi:10.1111/j.1440-1746.2010.06311.x.PubMedCrossRefGoogle Scholar
  20. 20.
    Berthoud HR. Anatomy and function of sensory hepatic nerves. Anat Rec A Discov Mol Cell Evol Biol. 2004;280:827–835. doi:10.1002/ar.a.20088.PubMedCrossRefGoogle Scholar
  21. 21.
    Bondini S, Kallman J, Dan A, et al. Health-related quality of life in patients with chronic hepatitis B. Liver Int. 2007;27:1119–1125. doi:10.1111/j.1478-3231.2007.01558.x.PubMedCrossRefGoogle Scholar
  22. 22.
    Fouad YM, Makhlouf MM, Khalaf H, Mostafa Z, Abdel Raheem E, Meneasi W. Is irritable bowel syndrome associated with chronic hepatitis C? J Gastroenterol Hepatol. 2010;25:1285–1288. doi:10.1111/j.1440-1746.2010.06311.x.Google Scholar
  23. 23.
    Elwing JE, Lustman PJ, Wang HL, Clouse RE. Depression, anxiety, and nonalcoholic steatohepatitis. Psychosom Med. 2006;68:563–569. doi:10.1097/01.psy.0000221276.17823.df.PubMedCrossRefGoogle Scholar
  24. 24.
    Kojima M, Kojima T, Suzuki S, et al. Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthr Rheum. 2009;61:1018–1024. doi:10.1002/art.24647.CrossRefGoogle Scholar
  25. 25.
    Laird BJ, Scott AC, Colvin LA, et al. Pain, depression, and fatigue as a symptom cluster in advanced cancer. J Pain Sympt Manage. 2011;42:1–11. doi:10.1016/j.jpainsymman.2010.10.261.CrossRefGoogle Scholar
  26. 26.
    Morasco BJ, Huckans M, Loftis JM, et al. Predictors of pain intensity and pain functioning in patients with the hepatitis C virus. Gen Hosp Psychiatry. 2010;32:413–418. doi:10.1016/j.genhosppsych.2010.03.010.PubMedCrossRefGoogle Scholar
  27. 27.
    Barkhuizen A, Rosen HR, Wolf S, Flora K, Benner K, Bennett RM. Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients. Am J Gastroenterol. 1999;94:1355–1360. doi:10.1111/j.1572-0241.1999.01087.x.PubMedGoogle Scholar
  28. 28.
    Dhingra L, Masson C, Perlman DC, et al. Epidemiology of pain among outpatients in methadone maintenance treatment programs. Drug Alcohol Depend. 2013;128:161–165. doi:10.1016/j.drugalcdep.2012.08.003.
  29. 29.
    Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008;94:38–47. doi:10.1016/j.drugalcdep.2007.09.018.
  30. 30.
    Sabin JA, Greenwald AG. The influence of implicit bias on treatment recommendations for 4 common pediatric conditions: pain, urinary tract infection, attention deficit hyperactivity disorder, and asthma. Am J Public Health. 2012;102:988–995. doi:10.2105/AJPH.2011.300621.PubMedCrossRefGoogle Scholar
  31. 31.
    Green CR, Hart-Johnson T. The association between race and neighborhood socioeconomic status in younger black and white adults with chronic pain. J Pain. 2012;13:176–186. doi:10.1016/j.jpain.2011.10.008.PubMedCrossRefGoogle Scholar
  32. 32.
    Williams DR. Race, socioeconomic status, and health. The added effects of racism and discrimination. Ann NY Acad Sci. 1999;896:173–188.PubMedCrossRefGoogle Scholar
  33. 33.
    Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain. 2008;138:440–449. doi:10.1016/j.pain.2008.04.027.Google Scholar
  34. 34.
    Nusrat S, Yadav D, Bielefeldt K. Pain and opioid use in chronic pancreatitis. Pancreas. 2012;41:264–270. doi:10.1097/MPA.0b013e318224056f.PubMedCrossRefGoogle Scholar
  35. 35.
    Parkman HP, Yates K, Hasler WL, et al. Similarities and differences between diabetic and idiopathic gastroparesis. Clin Gastroenterol Hepatol. 2011;9:1056–1064; quiz e133–e134. doi:10.1016/j.cgh.2011.08.013.
  36. 36.
    Noble M, Treadwell JR, Tregear SJ, et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev. 2010(1):CD006605. doi:10.1002/14651858.CD006605.pub2.
  37. 37.
    Nusrat S, Yadav D, Bielefeldt K. Pain and opioid use in chronic pancreatitis. Pancreas. 2012;41:264–267.Google Scholar
  38. 38.
    Barry DT, Goulet JL, Kerns RK, et al. Nonmedical use of prescription opioids and pain in veterans with and without HIV. Pain. 2011;152:1133–1138. doi:10.1016/j.pain.2011.01.038.PubMedCrossRefGoogle Scholar
  39. 39.
    Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, Sullivan LE. Gender and non-medical use of prescription opioids: results from a national US survey. Addiction. 2008;103:258–268. doi:10.1111/j.1360-0443.2007.02056.x.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Shari S. Rogal
    • 1
  • Daniel Winger
    • 2
  • Klaus Bielefeldt
    • 1
  • Eva Szigethy
    • 3
  1. 1.Division of Gastroenterology, Hepatology, and NutritionUniversity of PittsburghPittsburghUSA
  2. 2.Clinical and Translational Science InstituteUniversity of PittsburghPittsburghUSA
  3. 3.Department of PsychiatryUniversity of PittsburghPittsburghUSA

Personalised recommendations